Core Viewpoint - Antique projects CY26 as a potential turning point for Indian equities, anticipating a recovery in corporate profits and foreign portfolio investor (FPI) flows, with a target of 29,500 for the Nifty index, implying a 13% upside from current levels [1][13] Earnings Outlook - Nifty earnings are expected to grow at a compound annual rate of approximately 16% over FY26–28, significantly higher than the 7% CAGR recorded over FY24–26 [1][13] - The brokerage emphasizes an earnings-led market recovery rather than relying on multiple expansions, with corporate earnings positively correlated with wholesale price inflation and nominal GDP growth, both expected to normalize in FY27 [3][13] - A broad-based recovery in profits is anticipated, particularly in sectors such as electronics manufacturing services, telecom, industrials, and retail, while oil and gas, IT services, power utilities, FMCG, and automobiles are expected to lag [3][13] Capital Expenditure and Financials - The capital expenditure theme is expected to rebound after two years of slowdown, with favorable conditions across global monetary policies and domestic support [7][13] - Financials are a core focus, with expectations for banks to enter an earnings upcycle in CY26, supported by a strong domestic macro backdrop and the nearing end of the rate-cut cycle [8][13] - Public sector banks are favored due to comparable growth metrics to private lenders while trading at a 45% discount [8][13] Consumption Sector and Mid/Small-Cap Stocks - The broader consumption sector is viewed with caution due to high valuations and competitive pressures, although select discretionary segments like alcoholic beverages and hotels are seen positively [9][13] - Mid- and small-cap stocks are expected to show earnings growth that outpaces the Nifty over the next two to three years, driven by domestic cyclicals and increased capex activity [10][13] Stock Picks and Market Flows - Top large-cap stock picks include ICICI Bank, State Bank of India, and Hindustan Aeronautics, while mid-cap and small-cap preferences include Siemens Energy India and Chalet Hotels, respectively [11][13] - After a significant outflow of $17.5 billion from Indian equities in CY25, Antique anticipates stabilization and potential revival of FPI flows in CY26, supported by low FPI ownership and reasonable valuations [11][13] - Despite trading at a premium to historical averages, valuations are expected to be sustained due to lower bond yields and sectoral divergence, with many Nifty 500 stocks having corrected over 20% from their highs [12][13]

Core Insights - UPS has experienced significant changes in recent months, with its shares facing pressure due to increased competition in the Air Freight and Logistics sector and challenges with USPS [1] Company Overview - UPS is a prominent player in the Industrials sector, particularly in Air Freight and Logistics, which has seen rising competition impacting its stock performance [1] Market Dynamics - The company has been under pressure for years, indicating a challenging market environment that includes competition and operational difficulties [1]

Core View - The Indian equity market is expected to recover in 2026, supported by falling inflation, Reserve Bank of India rate cuts, stable domestic liquidity, and policy support for consumption and capital expenditure [1][19] Group 1: Market Outlook - Six leading brokerages project a positive outlook for Indian equities, with index targets clustered around mid-90,000s for the Sensex and close to 29,000–30,000 for the Nifty, indicating expectations of steady, earnings-led gains rather than valuation expansion [19] - Morgan Stanley forecasts the Sensex to rise to 95,000 by December 2026, driven by policy pivots supporting nominal growth and earnings compounding at a 17% CAGR through FY2028 [19] - BofA Securities targets the Nifty at 29,000 by end-2026, emphasizing that returns will largely track earnings growth rather than valuation expansion [7][19] Group 2: Preferred Sectors and Stocks - Financials, consumer discretionary, and industrials dominate the opportunity set, while telecom, autos, and select real estate plays add depth [1][19] - Morgan Stanley highlights Maruti Suzuki India, Trent, and Titan Company in consumer discretionary, with Bajaj Finance and ICICI Bank anchoring its financials call [5][19] - HSBC names Infosys as its top IT pick, State Bank of India as its favored PSU bank, and Mahindra & Mahindra as a key beneficiary in autos [6][19] - BofA's buy-rated universe includes airlines, autos, consumption, utilities, financials, and real estate, with specific mentions of Maruti Suzuki India, Mahindra & Mahindra, and Titan Company [9][10][19] Group 3: Investment Strategy - The brokerages prefer stocks with manageable expectations, strong balance sheets, and improving earnings visibility, resulting in a concentrated universe of names across various sectors [2][19] - Nomura urges investors to focus on areas with lower expectations and improving narratives, warning against crowded trades where valuations leave little room for disappointment [11][12][19] - Jefferies emphasizes sector rotation and valuation discipline, focusing on lending financials, telecom, property, autos, cement, and utilities [14][20] Group 4: Key Stock Picks - Key stock picks include Bajaj Finserv, Indian Oil Corporation, LTIMindtree, and Pidilite Industries, reflecting a combination of technical breakouts and improving fundamentals [17][20] - ICICI Direct's top picks include Bajaj Finserv, Indian Oil Corporation, and LTIMindtree, with a focus on sectors expected to benefit from stable interest rates and a pickup in domestic demand [16][20] Group 5: Conclusion - The six brokerages collectively identify 75 carefully chosen stocks that are expected to perform well in 2026, emphasizing the importance of substance over hype in the coming year [18][19]

Core Viewpoint - UBS analyst Steven Fisher maintains a Buy rating and a price target of $535 on Deere (DE) shares, indicating confidence in the company's future performance despite a slightly lower initial FY26 earnings guidance midpoint [1] Group 1: Earnings and Guidance - The Q4 results and outlook for Deere were described as "directionally consistent" with UBS's expectations, establishing 2026 as the agricultural bottom [1] - The initial FY26 earnings guidance midpoint is slightly lower than UBS's previous model, attributed mainly to a weak Q1 in North America [1] - UBS expresses increased confidence in 2026 as the earnings bottom and anticipates a recovery in 2027 following the report [1]

Core Insights - Wall Street is experiencing a solid earnings season, with strong sales and earnings per share (EPS) growth indicating a continuation of the bull market into next year [1][8] - Morgan Stanley's chief stock strategist highlights the importance of positive revenue surprises and EPS growth as key indicators of market strength [3][5] Sales and Earnings Growth - The sales growth rate of 2.3% is approximately double the typical rate of 1.1%, suggesting businesses are outperforming expectations in terms of sales [4] - The median companies in the Russell 3000 index achieved an 11% EPS growth, nearly double the second-quarter rate of 6%, indicating broad profit expansion across various sectors [5][6] Market Outlook - Analysts believe the current trends in sales and EPS growth support the view of a "rolling recovery" in earnings, with expectations for continued strength into 2026 [6][8] - The recent trade truce between the US and China has alleviated some trade tensions, which is seen as a positive development for the markets [7] Monetary Policy Considerations - There is uncertainty regarding interest rates, influenced by recent comments from Jerome Powell, which may affect the near-term monetary policy landscape [7][9]

Core Viewpoint - Astral Foods anticipates a rebound in earnings per share (EPS) for the full year, driven by a strong recovery in the second half of the fiscal year 2025 [1][2]. Financial Performance - EPS is expected to increase by 7% to 17%, reaching between R20.96 ($1.23) and R22.91, compared to R19.59 from the previous year [1]. - Headline earnings per share (HEPS) are projected to rise by 5% to 15%, estimated between R20.16 and R22.08, compared to R19.20 in the previous financial year [2]. Factors Contributing to Recovery - The recovery in the second half is attributed to increased broiler slaughter numbers and higher poultry sales compared to the previous year [2]. - Improved per-unit production costs due to higher production volumes and a recovery in poultry sales after a period of price deflation [2][3]. - Higher internal feed sales linked to increased broiler production and a year-on-year rise in external feed volumes contributed to the recovery [3]. Operational Insights - Astral Foods focused on rebuilding its balance sheet and successfully restored a targeted surplus cash position throughout the year [3]. - The company plans to publish final results around 17 November [3]. Previous Performance Context - In May, Astral Foods reported a decline in first-half profits due to lower poultry prices and higher feed costs, with revenue rising 3.5% to R10.7 billion ($593.5 million) [4]. - The poultry division's revenue increased by 1.5% to R8.8 billion, but it experienced an operating loss of R26 million, compared to a profit of R284 million the previous year [5].

Core Insights - UnitedHealth has faced challenges this year due to unexpectedly high medical costs, resulting in a significant stock decline of over 27% year to date and missing earnings expectations for the first time in over a decade [3][4] - The company's third quarter results showed a revenue increase of 12% year over year, totaling $113.2 billion, although net income fell by 61% to $2.3 billion [4] - UnitedHealth's CEO indicated progress in the company's turnaround strategy, which includes executive reshuffling and cost control measures [6][8] Financial Performance - Revenue for the third quarter reached $113.2 billion, reflecting a 12% increase compared to the previous year [4] - Net income decreased to $2.3 billion, a 61% decline year over year, but still exceeded analysts' expectations [4] - The company anticipates adjusted earnings of at least $16.25 per share for the current year [7] Strategic Outlook - UnitedHealth is focusing on operational improvements and prudent pricing strategies, aiming for solid earnings growth in the upcoming year [8] - The company is preparing for significant membership losses in 2026, expecting to lose about 1 million Medicare Advantage members and reduce Affordable Care Act enrollment by approximately two-thirds [8]

Summary of 2Q25 Pre-announcements for MSCI China and A-shares Industry Overview - The report focuses on the performance of the **A-share** and **MSCI China** markets for the second quarter of 2025 (2Q25) - A total of **1,528 A-share companies** (~30% by number of companies, ~25% by market cap) released pre-announcements, indicating a significant improvement from previous quarters [2][5][14] Key Findings A-share Market - The net negative alert ratio for A-shares in 2Q25 was **-4.8%**, similar to **-4.6%** in 2Q24 and significantly better than **-18.8%** in 4Q24 [8][17] - By market cap, the net positive alert ratio reached **+4.7%**, up from **+2.8%** in 2Q24 and **-0.7%** in 4Q24 [8][17] - Large-cap companies showed resilience with a net negative alert of **-1.4%**, while small-cap companies improved to **-7.4%** from **-31.1%** in 4Q24 [8][17] - Financial Services, Materials, and Technology Hardware sectors recorded the highest net positive alerts, while Consumer Services, Real Estate, and Software sectors had the largest net negative alerts [8][17] MSCI China Market - The MSCI China universe reported a net positive alert ratio of **+6.8%**, improving from **+1.4%** in 2Q24 and **+2.2%** in 4Q24 [9][30] - **69 stocks** announced positive alerts compared to **31 companies** with negative alerts [33] - Financials and Materials sectors had the highest net positive alerts, while Real Estate and Utilities sectors had the most net negative alerts [33][34] Earnings Estimates Revisions - As of July 18, 2025, **240 MSCI China constituents** (~47% by number of companies) had earnings estimates revised by more than **1%** [2][36] - A net **11%** of MSCI China constituents saw 2025 consensus earnings estimates revised downward [13][37] - By index weight, a net **0%** of MSCI China saw 2025 consensus earnings estimates raised during the assessment period [37] Stock Recommendations - Based on the analysis, **nine stocks** were identified as favorable investments, while **six stocks** were deemed to face challenges going into the 2Q25 results season [12][59] - The positively screened stocks include companies from sectors such as Materials, Pharmaceuticals, and Automotive, with specific tickers and price targets provided [59] Additional Insights - The report highlights the uneven recovery across different market capitalizations, with large-cap companies performing better than mid and small-cap companies [17] - The overall sentiment indicates a cautious optimism for the upcoming earnings season, with a focus on sectors that have shown resilience and potential for growth [47][51] This summary encapsulates the key points from the 2Q25 pre-announcements for MSCI China and A-shares, providing insights into market performance, sector dynamics, and stock recommendations.